Cost-effectiveness of point-of-care biomarker assessment for suspected myocardial infarction: the randomized assessment of treatment using panel Assay of cardiac markers (RATPAC) trial.

Cost-effectiveness of point-of-care biomarker assessment for suspected myocardial infarction: the randomized assessment of treatment using panel Assay of cardiac markers (RATPAC) trial.

Item
http://www.wikidata.org/entity/Q37875216
The Manchester Acute Coronary Syndromes (MACS) decision rule for suspected cardiac chest pain: derivation and external validation.Anatomic distribution of culprit lesions in patients with non-ST-segment elevation myocardial infarction and normal ECG.A Systematic Review of Health Economic Evaluations of Diagnostic Biomarkers.Factors Influencing Time-Dependent Quality Indicators for Patients With Suspected Acute Coronary Syndrome.Economic Evidence and Point-of-Care Testing.Assessing the value of cardiac biomarkers: going beyond diagnostic accuracy?Feasibility of the Manchester Acute Coronary Syndromes (MACS) decision rule to safely reduce unnecessary hospital admissions: a pilot randomised controlled trial.Editor's Choice-The organization of chest pain units: Position statement of the Acute Cardiovascular Care Association.The Manchester Acute Coronary Syndromes (MACS) decision rule: validation with a new automated assay for heart-type fatty acid binding protein.Point-of-care testing (POCT) and evidence-based laboratory medicine (EBLM) - does it leverage any advantage in clinical decision making?Randomised controlled trial of the Limit of Detection of Troponin and ECG Discharge (LoDED) strategy versus usual care in adult patients with chest pain attending the emergency department: study protocol
P2860

Cost-effectiveness of point-of-care biomarker assessment for suspected myocardial infarction: the randomized assessment of treatment using panel Assay of cardiac markers (RATPAC) trial.

Item
http://www.wikidata.org/entity/Q37875216
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cost-effectiveness of point-of ...... ardiac markers (RATPAC) trial.
@en
Cost-effectiveness of point-of ...... panel Assay of cardiac markers
@nl
type
label
Cost-effectiveness of point-of ...... ardiac markers (RATPAC) trial.
@en
Cost-effectiveness of point-of ...... panel Assay of cardiac markers
@nl
prefLabel
Cost-effectiveness of point-of ...... ardiac markers (RATPAC) trial.
@en
Cost-effectiveness of point-of ...... panel Assay of cardiac markers
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P356
P1433
P1476
Cost-effectiveness of point-of ...... ardiac markers (RATPAC) trial.
@en
P2093
P2860
P304
P31
P356
10.1111/J.1553-2712.2011.01068.X
P433
P478
P50
P577
P5875
P698
P921